arrow
O

Octavio Burgués

hospital universitario de valencia
H指数:25
被引数:2,128

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A decade of human epidermal growth factor receptor 2 (HER2) testing in breast cancer in Spain: A comprehensive real-world data analysis (2013-2023)

十年间西班牙乳腺癌中人类表皮生长因子受体2(HER2)检测:一项全面的真实世界数据分析(2013-2023)

2026-04-090
PRE
Personalized treatment approaches with HER2DX in early HER2-positive breast cancer: A precision tool for treatment decision-making

HER2DX个性化治疗策略在早期HER2阳性乳腺癌中的应用:治疗决策制定的精准工具

2024-09-010
PRE
Targeted immunotherapy against distinct cancer-associated fibroblasts overcomes treatment resistance in refractory HER2+breast tumors
2022-09-0928
OAAI
Aurora kinase overexpression may play a role in PARPi resistance in tumor samples of patients with high grade ovarian cancer and its inhibition with alisertib overcomes resistance to olaparib in a PARPi-resistant cell line model
2022-09-010
OAAI
Targeting HER2-AXL heterodimerization to overcome resistance to HER2 blockade in breast cancer
2022-05-2033
OAAI
Interobserver variability in the assessment of stromal tumor-infiltrating lymphocytes (sTILs) in triple-negative invasive breast carcinoma influences the association with pathological complete response: the IVITA study
2021-12-0122
OAAI
First Nationwide Molecular Screening Program in Spain for Patients With Advanced Breast Cancer: Results From the AGATA SOLTI-1301 Study
2021-11-044
OAAI
Patient follow-up of NEOVATTL study
2021-05-010
OAAI
FGFR4 regulates tumor subtype differentiation in luminal breast cancer and metastatic disease

FGFR4调节管腔型乳腺癌和转移性疾病的肿瘤亚型分化

2020-08-1758
OA
The GATA3 X308_Splice breast cancer mutation is a hormone context-dependent oncogenic driver
2020-06-2511
OAAI
AXL-HER2 dimer as mechanism of anti-HER2 acquired resistance in HER2 amplified brest cancer models: A new step towards precision medicine
2020-02-150
PRE
Aurora kinases in ovarian cancer

卵巢癌中的Aurora激酶

2020-01-0119
OAAI